Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET

Hong Kong's Insilico reaches $2.75 billion Eli Lilly deal for AI-developed drugs

Name: Hong Kong's Insilico reaches $2.75 billion Eli Lilly deal for AI-developed drugs
Uploaded: 2026-03-30T05:27:05.000Z
Duration: 2 min 27 s
Description: Hong-Kong listed Insilico Medicine has announced a new $2.75 billion deal with U.S. pharmaceutical giant Eli Lilly, which will see both firms leveraging on artificial intelligence for future pharmaceutical research. CNBC's Evelyn Cheng reports from Beijing.

Hong-Kong listed Insilico Medicine has announced a new $2.75 billion deal with U.S. pharmaceutical giant Eli Lilly, which will see both firms leveraging on artificial intelligence for future pharmaceutical research. CNBC's Evelyn Cheng reports from Beijing.

02:27

Mon, Mar 30 20261:27 AM EDT